Abstract
We evaluated the Syva MicroTrak Chlamydia Blocking Antibody Assay as a confirmatory assay for the detection of Chlamydia trachomatis in urogenital specimens. During a 5-month period, 109 positives were obtained (4.9%) by the MicroTrak II Enzyme Immunoassay as implemented with the Syva XL automated enzyme immunoassay instrument. Of 98 evaluable samples, 92 (93.9%) were confirmed as positive by the blocking assay, and 3 blocking-negative samples had organisms detected by direct fluorescent-antibody analysis (blocking sensitivity, 96.8%). We found that direct fluorescent-antibody analysis of samples with a specimen-to-cutoff absorbance ratio of < or = 2.0 was a reasonable confirmation alternative and was more cost-effective than the blocking assay.
Full Text
The Full Text of this article is available as a PDF (166.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chan E. L., Brandt K., Horsman G. B. A 1-year evaluation of Syva MicroTrak Chlamydia enzyme immunoassay with selective confirmation by direct fluorescent-antibody assay in a high-volume laboratory. J Clin Microbiol. 1994 Sep;32(9):2208–2211. doi: 10.1128/jcm.32.9.2208-2211.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kellogg J. A., Seiple J. W., Klinedinst J. L., Levisky J. S. Impact of endocervical specimen quality on apparent prevalence of Chlamydia trachomatis infections diagnosed using an enzyme-linked immunosorbent assay method. Arch Pathol Lab Med. 1991 Dec;115(12):1223–1227. [PubMed] [Google Scholar]
- Olsen M. A., Sambol A. R. Confirmation of positive results for chlamydial antigen by the Chlamydiazyme assay: value of repeated testing and a blocking antibody assay. J Clin Microbiol. 1993 Jul;31(7):1892–1895. doi: 10.1128/jcm.31.7.1892-1895.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]